Loading clinical trials...
Loading clinical trials...
Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer
Conditions
Interventions
Vaccine
Locations
1
United States
Levine Cancer Institute
Charlotte, North Carolina, United States
Start Date
August 8, 2022
Primary Completion Date
October 1, 2030
Completion Date
October 1, 2030
Last Updated
January 22, 2026
NCT06612645
NCT05918640
NCT06055296
NCT06423950
NCT07368582
NCT02813135
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions